Spinocerebellar Ataxia Type 7 (SCA7) Gene Mutation Analysis
Spinocerebellar ataxia-7 (SCA7) is an autosomal dominant neurodegenerative disorder characterized by adult onset of progressive cerebellar ataxia associated with pigmental macular dystrophy. In infancy and early childhood, SCA7 is associated with muscle weakness, wasting, hypotonia, poor feeding, failure to thrive and failure to achieve motor milestones. In younger-onset patients, visual acuity and blue-yellow color vision (tritanopia) changes are the earliest signs of the disease. In adult-onset disease, visual symptoms (hemeralopia, photophobia, abnormalities in color vision and central visual acuity) may occur along with cerebellar ataxia.
SCA7 is caused by expanded CAG trinucleotide repeat in the ATXN7 gene (3p21.1-p12) and inherited in an autosomal dominant pattern. This mutation leads to degeneration in the cells of the retina, cerebellum and brainstem. The prevalence of SCA7 is estimated to be less than 1/100,000.
- Diagnosis of spinocerebellar ataxia type 7 (SCA7) in patients with cerebellar ataxia and visual disturbance
- For the diagnosis of SCA7 in symptomatic family members of known SCA7 patients
- For prenatal diagnosis in families with a known ATXN7 mutation
Normal
- 4-18 CAG trinucleotide repeat in the ATXN7 gene
Abnormal
- 36-38 CAG trinucleotide repeat in the ATXN7 gene
Normal: < 18 CAG trinucleotide repeats in the ATXN7 gene
Whole blood (EDTA lavender top tube).
Stability
- Room temperature: 3-5 days
- Refrigerated: 7-14 days
- Frozen: Unacceptable
- Cerebellum. 2008;7: 138-149. [PMID: 18418675]
- PLoS One. 2009;4: e7232. [PMID: 19789634]
- Ophthalmic Genet. 2009;30: 1-6. [PMID: 19172503]
- Eur J Hum Genet. 2004;12: 2-15. [PMID: 14571264]
- J Neurol. 2001;248: 911-4. [PMID: 11697534]
- Arch Neurol. 2000;57: 1513-8. [PMID: 11030806]
- Ophthalmic Paediatr Genet. 1993;14: 61-7. [PMID: 8233354]